Bristol-Myers Squibb Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 19,348.0 | 17,914.0 | 19,207.0 |
| Cost of Goods Sold | 6,218.0 | 5,956.0 | 5,928.0 |
| Gross Profit | 13,130.0 | 11,958.0 | 13,279.0 |
| Gross Profit Margin | 67.9% | 66.8% | 69.1% |
| SG&A Expense | 8,864.0 | 8,571.0 | 8,168.0 |
| Depreciation & Amortization | 892.0 | 927.0 | 929.0 |
| Operating Income | 3,374.0 | 2,460.0 | 4,182.0 |
| Operating Margin | 17.4% | 13.7% | 21.8% |
| Nonoperating Income | 160.0 | 199.0 | 334.0 |
| Nonoperating Expenses | -- | 498.0 | -- |
| Income Before Taxes | 3,534.0 | 2,635.0 | 4,516.0 |
| Income Taxes | 803.0 | 610.0 | 932.0 |
| Net Income After Taxes | 2,731.0 | 2,025.0 | 3,584.0 |
| Continuing Operations | 1,968.0 | 1,585.0 | 2,992.0 |
| Discontinued Operations | 197.0 | -- | 8.0 |
| Total Operations | 2,165.0 | 1,585.0 | 3,000.0 |
| Total Net Income | 2,165.0 | 1,585.0 | 3,000.0 |
| Net Profit Margin | 11.2% | 8.8% | 15.6% |
| Diluted EPS from Total Net Income ($) | 1.09 | 0.81 | 1.52 |
| Dividends per Share | 1.12 | 1.12 | 1.12 |





